Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kuss BJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sulda, ML, Kuss, BJ, Hall, RK, Bailey, S, Macardle, PJ
Background: Chronic lymphocytic leukaemia (CLL) is a clinically heterogeneous disease. While immunoglobulin variable region heavy chain (IgVH) mutational status remains the ‘gold standard’ in molecular prognostication, a range of additional marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1231::b93fd17ebc01a19811c7fa1463cf6967
https://hdl.handle.net/11541.2/136716
https://hdl.handle.net/11541.2/136716
Autor:
Allan JN; Weill Cornell Medicine, New York, New York., Flinn IW; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Siddiqi T; City of Hope National Medical Center, Duarte, California., Ghia P; Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Tam CS; Peter MacCallum Cancer Center and St. Vincent's Hospital and the University of Melbourne, Melbourne, Victoria, Australia., Kipps TJ; UCSD Moores Cancer Center, San Diego, California., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York., Elinder Camburn A; North Shore Hospital/Waitematā District Health Board, Auckland, New Zealand., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Badoux XC; Ministry of Health, Kogarah, New South Wales, Australia., Jacobs R; Levine Cancer Institute, Charlotte, North Carolina., Kuss BJ; Flinders University and Medical Centre, Bedford Park, South Australia, Australia., Trentin L; University of Padova, Padova, Italy., Zhou C; Pharmacyclics LLC, an AbbVie Company, South San Francisco, California., Szoke A; Pharmacyclics LLC, an AbbVie Company, South San Francisco, California., Abbazio C; AbbVie, South San Francisco, California., Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 14; Vol. 29 (14), pp. 2593-2601.
Autor:
White AM; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia., Best OG; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia., Hotinski AK; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia., Kuss BJ; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia., Thurgood LA; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Publikováno v:
Metabolites [Metabolites] 2023 Jun 27; Vol. 13 (7). Date of Electronic Publication: 2023 Jun 27.
Autor:
Tam CS; Peter MacCallum Cancer Center, Melbourne, VIC, Australia.; St. Vincent's Hospital, Melbourne, VIC, Australia.; University of Melbourne, Melbourne, VIC, Australia., Allan JN; Weill Cornell Medicine, New York, NY., Siddiqi T; City of Hope National Medical Center, Duarte, CA., Kipps TJ; Moores Cancer Center, University of California San Diego, San Diego, CA., Jacobs R; Levine Cancer Institute, Charlotte, NC., Opat S; Monash University, Clayton, VIC, Australia., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Trentin L; University of Padova, Padova, Italy., Bannerji R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Jackson S; Middlemore Hospital, Auckland, New Zealand., Kuss BJ; Flinders University and Medical Center, Bedford Park, SA, Australia., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain., Szafer-Glusman E; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Russell K; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Zhou C; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Ninomoto J; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Dean JP; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Ghia P; Università Vita-Salute San Raffaele, Milan, Italy; and.; IRCCS Ospedale San Raffaele, Milan, Italy.
Publikováno v:
Blood [Blood] 2022 Jun 02; Vol. 139 (22), pp. 3278-3289.
Autor:
Thurgood LA; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, Australia. Electronic address: lauren.thurgood@flinders.edu.au., Best OG; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, Australia., Rowland A; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, Australia., Lower KM; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, Australia., Brooks DA; Cancer Research Institute, University of South Australia, Adelaide, Australia., Kuss BJ; Molecular Medicine and Genetics, College of Medicine and Public Health, Flinders University, Bedford Park, Australia.
Publikováno v:
Experimental hematology [Exp Hematol] 2022 Feb; Vol. 106, pp. 58-67. Date of Electronic Publication: 2021 Dec 08.